Material Transfer Agreement (MTA)
Materials are typically the starting point, or at least play a crucial role in creating new innovations. As a result, the use of materials is potentially very valuable for generating novel intellectual property.
The MTA defines the intellectual property rights of the provider and the recipient with respect to the materials and any derivatives. Biological materials, such as reagents, cell lines, plasmids, and vectors, are the most frequently transferred materials. However, MTAs may also be used for other types of materials, such as chemical compounds and even some types of software.
Below are customized MTAs for our most frequently requested materials organized by Principal Investigator (PI).
Download the appropriate MTA. Complete the MTA in its entirety. Any missing information could result in delayed processing.
For foreign entities, be sure to complete both Appendix A and Appendix B of the MTA.
Once you have obtained the appropriate signature, either fax copy of the MTA to 1-505-665-0154 (Attn: MTA Processing) or email a scanned copy of the MTA to email@example.com.
Green Fluorescent Protein (GFP) Materials
LANL has teamed up with a local biotechnology company to distribute many of the GFP components. As of November 15, 2008, non-commercial entities interested in obtaining LANL's in vitro Split GFP, Superfolder GFP, or a mammalian codon-optimized version of the in vivo Split GFP plasmids need to obtain the materials through our partner, Sandia Biotech, Inc. All commercial parties interested in licensing these materials should visit LANL's GFP licensing page.